Press Releases

click here to view recent releases

Fact Sheet

click here to view our latest fact sheet

Letter to Shareholders

click here to view our 2015 letter to shareholders

In the News

click here to view The Search for a ‘Safer’ Ketamine

click here to view CanadaAM video

click here
 to view CTV News video


click here to view rhythmically beating engineered human heart tissue from pluripotent stem cells

Information Request

click here to sign up

Investor Media Contact

Shawn K. Singh, JD
Chief Executive Officer
VistaGen Therapeutics, Inc.
T: 650-577-3600